Commonwealth Bank of Australia’s Ironwood Pharmaceuticals IRWD Stock Holding History

Commonwealth Bank of Australia’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-72,870	Closed	-$752K	–	917
2014 Q1	$752K	Buy	72,870 +10,734	+17%	+$121K	﹤0.01%	907
2013 Q4	$604K	Buy	62,136 +7,928	+15%	+$71.2K	﹤0.01%	947
2013 Q3	$538K	Hold	54,208	–	–	﹤0.01%	941
2013 Q2	$451K	Buy	+54,208	New	+$657K	﹤0.01%	975

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Commonwealth Bank of Australia's IRWD Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2014, closing a stake of 72,870 shares — an estimated $752K sold.

Commonwealth Bank of Australia first reported a position in IRWD in Q2 2013 and held it in 4 quarters. The position peaked at $752K in Q1 2014. 138 funds tracked by Wall St. Rank hold IRWD as of Q2 2014.

Commonwealth Bank of Australia reported no remaining Ironwood Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Commonwealth Bank of Australia sold 72,870 Ironwood Pharmaceuticals shares in Q2 2014, an estimated $752K.
Commonwealth Bank of Australia first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Commonwealth Bank of Australia's Ironwood Pharmaceuticals position peaked at $752K in Q1 2014.
138 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.